In summary, our work confirms that CUL4A regulates the expression of MDR1 via an ERK1/2 dependent signaling pathway in breast cancer cells, which is consistent with their alterations in cellular multidrug resistance in vitro. Here, MAPK3 is linked to breast cancer.